Sézary syndrome treated with narrowband ultraviolet B: Time-course measurement of serum levels of CCL17/CCL27

Clinical and Experimental Dermatology

Volumn 32, Issue 1, 2007, Pages 57-59

  Masui, Y ^a   Sugaya, M ^a   Kagami, S ^a   Fujita, H ^a   Yano, S ^a   Nagao, M ^a   Komine, M ^a   Saeki, H ^a   Ihn, H ^a   Kikuchi, K ^a   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE CCL27; PREDNISOLONE; PSORALEN; STEROID; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUVA; SEZARY CELL; SEZARY SYNDROME; SKIN BIOPSY; TREATMENT FAILURE; ULTRAVIOLET B RADIATION;

ADULT; CHEMOKINES, CC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; SEZARY SYNDROME; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 33845780145     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02261.x     Document Type: Article

References (10)

1. Vonderheid EC, Bernengo MG, Burg G et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002; 46: 95-106.
2. Diederen PV, van Weelden H, Sanders CJ et al. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. J Am Acad Dermatol 2003; 48: 215-19.
3. Ghodsi SZ, Hallaji Z, Balighi K et al. Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients. Clin Exp Dermatol 2005; 30: 376-8.
4. Reiss Y, Proudfoot AE, Power CA et al. CC chemokine receptor (CCR) 4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001; 194: 1541-7.
5. Imai T, Baba M, Nishimura M et al. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997; 272: 15036-42.
6. Homey B, Wang W, Soto H et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK / ALP / ILC). J Immunol 2000; 164: 3465-70.
7. Kakinuma T, Sugaya M, Nakamura K et al. Thymus and activation-regulated chemokine (TARC / CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 2003; 48: 23-30.
8. Kagami S, Sugaya M, Minatani Y et al. Elevated serum CTACK / CCL27 levels in CTCL. J Invest Dermatol 2006; 126: 1189-91.
9. Sokolowska-Wojdylo M, Wenzel J, Gaffal E et al. Circulating clonal CLA (+) and CD4 (+) T cells in Sézary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 2005; 152: 258-64.
10. Murakami T, Cardones AR, Finkelstein SE et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 2003; 198: 1337-47.